Cited by 227Advanced Glycation End Products researchChronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Renal catabolism of advanced glycation end products: the fate of pentosidine

Open access
Miyata, Toshio, Ueda, Yasuhiko, Horie, Katsunori, Nangaku, Masaomi, Tanaka, Shuichi, de Strihou, Charles van Ypersele, Kurokawa, Kiyoshi·1998·Kidney International

Abstract

Advanced glycation end products (AGEs) generated through the Maillard reaction significantly alter protein characteristics. Their accumulation has been incriminated in tissue injury associated with aging, diabetes, and renal failure. However, little is known about their clearance from the body. The present study delineates the catabolic pathway of a well-defined AGE product, pentosidine. Synthesized pentosidine given intravenously in rats with normal renal function was rapidly eliminated from the circulation through glomerular filtration, but was undetectable in the urine by chemical analysis. Immunohistochemistry with anti-pentosidine antibody disclosed that pentosidine accumulated transiently in the proximal renal tubule one hour after its administration, but had disappeared from the kidney at 24 hours. After an intravenous load of radiolabeled pentosidine, radioactivity peaked in the kidney at one hour and subsequently decreased, whereas it rose progressively in the urine. Over 80% of the radioactivity was recovered in the 72-hour collected urine. However, only 20% of urine radioactivity was associated with intact pentosidine chemically or immunochemically. In gentamicin-treated rats with tubular dysfunction, up to 30% of the pentosidine load was recovered as intact pentosidine in the urine. The present study suggests that free pentosidine (and possibly other AGEs) is filtered by renal glomeruli, reabsorbed in the proximal tubule where it is degraded or modified, and eventually excreted in the urine. Kidney thus plays a key role in pentosidine disposal.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1523-1755.1998.00756.x

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased abdominal fat mass is associated with chronic elevation of circulating inflammatory mediators including CRP, cytokines, adhesion molecules and pro-thrombotic molecules.

    “The increase in abdominal fat mass is associated with a chronic elevation of the circulating concentrations of inflammatory mediators including several acute-phase inflammatory proteins such as CRP (46,47) , proand anti-inflammatory cytokines, adhesion molecules and pro-thrombotic molecules (22,47 -49) .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., de Strihou, C. V. Y., & Kurokawa, K.
Affiliations
Tokai University (JP)
Corresponding author
Miyata, Toshio
Venue
Kidney International
Publisher
Elsevier BV
Published
1998-02
Volume
53
Issue
2
Pages
416-422
ISSN
0085-2538 (ISSN-L)
OpenAlex
W1998110176
Cited by
227
References
26
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 8 · 2020: 12 · 2019: 10 · 2018: 4 · 2017: 12 · 2016: 1 · 2015: 10 · 2014: 5 · 2013: 11 · 2012: 8
FWCI
5.77
Type
journal article
Language
en
Open access
Locations
  • Kidney International (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (96L00303)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords
advanced glycation end products, pentosidine, Maillard reaction, glomerular filtration, proximal tubule, tubular reabsorption, urinary excretion, renal clearance, protein glycation
MeSH terms
Animals, Anti-Bacterial Agents, Arginine, Chromatography, High Pressure Liquid, Gentamicins, Kidney Diseases, Kidney Glomerulus, Kidney Tubules, Proximal, Lysine, Protein Synthesis Inhibitors, Glycation End Products, Advanced, Rats, Wistar, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review